e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Clinical application of exhaled biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pattern of exhaled volatile organic compounds is altered in children with obstructive sleep apnea
Z. Lázár, A. Bikov, P. Benedek, L. Kunos, I. Horváth (Budapest, Hungary)
Source:
Annual Congress 2011 - Clinical application of exhaled biomarkers
Session:
Clinical application of exhaled biomarkers
Session type:
Oral Presentation
Number:
1697
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Lázár, A. Bikov, P. Benedek, L. Kunos, I. Horváth (Budapest, Hungary). Pattern of exhaled volatile organic compounds is altered in children with obstructive sleep apnea. Eur Respir J 2011; 38: Suppl. 55, 1697
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert view on treatment approach to children with persistent obstructive sleep apnoea
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Overnight changes in exhaled carbon monoxide levels in obstructive sleep apnoea
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
The role of inflammatory mediator in exhaled breath condensate of obstructive sleep apnea
Source: Eur Respir J 2004; 24: Suppl. 48, 331s
Year: 2004
Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Spirometry and nocturnal oxygen saturation in patients with obstructive sleep apnoea with and without COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 568s
Year: 2005
Factors influencing airway inflammation measured by exhaled NO levels in a population with obstructive sleep apnea syndrome (OSA)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Diurnal variation of exhaled nitric oxide in obstructive sleep apnea syndrome and healthy subjects
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Effect of nasal CPAP on exhaled nitric oxide in patients with obstructive sleep apnea
Source: Eur Respir J 2007; 30: Suppl. 51, 332s
Year: 2007
Effects of changing the properties of breathing gas on the collapsibility of the upper airway in patients with obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 12s
Year: 2002
An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Peculiarities of GABA levels in plasma and urine of asthma patients with obstructive sleep apnea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
Overnight transcutaneous carbon dioxide monitoring in eucapneic patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013
Effects of reduced lung volumes and age on oxyhemoglobin nocturnal desaturation in obstructive sleep apnea patients before and after CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Effects of continuous nocturnal high oxygen concentrations in obstructive sleep apnea patients
Source: Annual Congress 2005 - Control of breathing
Year: 2005
Patients with obstructive sleep apnoea free of nasal obstruction have increased oral breathing
Source: Annual Congress 2007 - Pathogenesis of obstructive sleep apnoea
Year: 2007
Peculiarities of nocturnal oxygen saturation in obstructive sleep apnoea
Source: Eur Respir J 2004; 24: Suppl. 48, 119s
Year: 2004
Volatile organic compounds in exhaled breath in preschool children with and without recurrent wheeze
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Utility of awake oxygen saturation to identify obstructive sleep apnoea
Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Year: 2019
Measures of nocturnal oxyhemoglobin desaturation in children with obstructive lung disease or sleep-disordered breathing
Source: International Congress 2018 – Improvements in the assessment of paediatric physiology
Year: 2018
Prevalence of complex sleep apnea among German patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept